Postoperative AKI Management
The management of postoperative acute kidney injury centers on optimizing hemodynamics through fluid and vasopressor support, eliminating nephrotoxic exposures, and implementing supportive care—there is no specific pharmacologic therapy proven to reverse established AKI. 1, 2
Immediate Assessment and Diagnosis
Confirm AKI using KDIGO criteria: serum creatinine increase ≥0.3 mg/dL within 48 hours OR ≥50% increase within 7 days OR oliguria (<0.5 mL/kg/hr for >6 hours). 1 Stage the severity (1-3) as this guides intensity of intervention and prognosis.
Core Management Principles
1. Hemodynamic Optimization
Fluid management is the cornerstone but must be carefully balanced to avoid both hypovolemia and fluid overload. 1, 2
- Restore euvolemia using clinical assessment and functional hemodynamic monitoring in high-risk patients
- Prefer balanced crystalloids over normal saline to avoid hyperchloremic acidosis, though definitive harm from saline remains under investigation 1
- Avoid aggressive fluid resuscitation once euvolemic—fluid overload worsens outcomes and there are no established thresholds for when to stop 1
- Use vasopressors (norepinephrine preferred) in conjunction with fluids for vasomotor shock to maintain adequate perfusion pressure 2
- Avoid hypotension aggressively—even brief episodes increase AKI risk 3
2. Eliminate Nephrotoxic Exposures
Stop all nephrotoxic medications immediately unless they are life-saving. 1
- Discontinue NSAIDs (avoided in 97% of cases in practice) 4
- Hold or reduce diuretics unless managing fluid overload (withheld in 82% of cases) 4
- Discontinue ACE inhibitors/ARBs temporarily in the acute setting, though timing of reinitiation remains controversial 1
- Avoid aminoglycosides, contrast agents when possible, and review all renally-cleared medications for dose adjustment 1, 3
- Do NOT withhold life-saving nephrotoxic agents (e.g., IV contrast in critical situations) due to AKI concern 1
3. Supportive Care
- Target glucose 110-149 mg/dL with insulin therapy in critically ill patients 2
- Provide 20-30 kcal/kg/day total energy 2
- Protein intake:
- 0.8-1.0 g/kg/day if not on dialysis and non-catabolic
- 1.0-1.5 g/kg/day if on RRT
- Up to 1.7 g/kg/day if on CRRT or hypercatabolic 2
- Do NOT restrict protein to delay dialysis—this is ineffective 2
- Prefer enteral over parenteral nutrition 2
4. Monitor and Adjust
- Serial creatinine and urine output monitoring to track trajectory 1
- Correct electrolyte abnormalities (hyperkalemia, metabolic acidosis)
- Consider sodium bicarbonate for severe metabolic acidosis, though evidence is limited 1
Renal Replacement Therapy
Initiate RRT for absolute indications: refractory hyperkalemia, severe metabolic acidosis, uremic complications (pericarditis, encephalopathy), or severe fluid overload unresponsive to diuretics. 1
Optimal timing, dose, and modality remain areas of active investigation—no evidence supports early "prophylactic" RRT. 1
Critical Pitfalls
- Intraoperative oliguria does not always indicate AKI or require aggressive fluid administration—it may be physiologic stress response 3
- Opioid dose reduction is frequently neglected (only 5% of cases) despite renal clearance concerns 4
- AKI documentation is poor: only 64% in clinical notes and 39% in discharge summaries 4
- Outpatient follow-up is inadequate: only 59% receive lab follow-up within 30 days and only 7% get nephrology referral 4
Post-Discharge Management
Ensure nephrology follow-up for stage 2-3 AKI and arrange creatinine monitoring within 2-4 weeks of discharge. 4 Even mild AKI increases long-term CKD and mortality risk, making surveillance essential despite current practice gaps. 5, 4
The 30-day mortality for postoperative AKI remains 18%, underscoring that prevention through preoperative risk assessment and intraoperative renal protection is far more effective than treatment of established injury. 6, 7, 3, 4